Moreover, sEV-tirzepatide exhibited a more profound and long-lasting effect in this diabetic mouse model, as evidenced by the lower blood glucose levels at later time points (Figure 5)
Common Side Effects and Mitigation Strategies While semaglutide is generally well-tolerated, some individuals may experience side effects, particularly during the initial titration phase
4, the three most frequently reported SOC categories were "Gastrointestinal disorders," "General disorders and administration site conditions," and "Investigations." Notably, while "Injury, poisoning, and procedural complications" and "Nervous system disorders" demonstrated higher reporting frequencies compared to other SOCs, these associations did not reach statistical significance in our analysis, suggesting potential reporting bias or confounding factors that warrant further investigation
This means the healthcare provider must justify the need for this specific medication